Summary: The tolerability of Lomustin VÚFB with 53 patients was good. Myelotoxicity corresponds to literary data with Lomustin of other provenience, Gastrointestinal toxicity was in diameter lower. The antitumor activity (25% of remission rates) is also on the same level with different type of tumors as in indicated in literature.
Clinical value of the preparation Lomustin VÚFB
